EXPERIMENTAL
1
The H NMR spectra were obtained on a Bruker WP 400 (400 MHz) instrument in CDCl3, internal
standard TMS. The IR spectra were recorded on a INFRALYUM FT 801 Fourier spectrometer in KBr pellets.
The ESI mass spectra were recorded on a Agilent 1100 Series LC/MSD Trap System VL mass spectrometer.
Silufol UV 254 plates were used for TLC (visualization with iodine vapor), neutral Al2O3 Fluka 507c (size
0.05-0.15 mm) was used for column chromatography.
2-Ethyl-3,3,5,5-tetramethyl-1,2,4,5-tetrahydro-3H-benz-2-azepine (3) and 2-Ethyl-1,3,3,5,5-penta-
methyl-1,2,4,5-tetrahydro-3H-benz-2-azepine (4) (General Method). Anhydrous potassium carbonate (10 g,
72 mmol) was added to a solution of azepines 1 or 2 (48 mmol) in DMF (25 ml). After 15 min ethyl iodide
(10.92 g, 5.6 ml, 70 mmol) was added dropwise. The mixture was heated at 60oC until disappearance of the
starting material (check by TLC). The mixture was poured into water (100 ml), extracted with ether, and the
extract dried over magnesium sulfate. After distilling off the solvent (DMF in vacuum) the residue was
chromatographed, eluent ethyl acetate–hexane, 1:20. Azepines 3 (6.8 g: 68%) and 4 (4.5 g: 38.3%) were
isolated.
Compound 3. Yellow oil. 1H NMR spectrum, δ, ppm (J, Hz): 1.08 (3H, t, J = 7.2, CH3CH2); 1.15 (3H,
s, CH3); 1.17 (3H, s, CH3); 1.31 (1H, d, J = 13.8, H-1); 1.35 (3H, s, CH3); 1.3 (3H, s, CH3); 1.42 (3H, s, CH3);
1.61 (1H, d, J = 13.8, H-4); 2.67 (2H, q, J = 7.2, CH3CH2); 3.67 (1H, d, J = 15.1, H-1); 4.18 (1H, d, J = 15.1,
H-1); 7.13-7.32 (4H, m, H Ar). Found, %: C 83.29; H 11.00; N 6.26. M+ 231. C16H25N. Calculated, %: C 82.91;
H 10.82; N 6.01. M 231.
Compound 4. Yellow oil. 1H NMR spectrum, δ, ppm (J, Hz): 1.03 (3H, t, J = 7.2, CH3CH2); 1.05 (3H,
s, CH3); 1.26 (3H, s, CH3); 1.42 (3H, s, CH3); 1,51 (3H, s, CH3); 1.53 (3H, d, J = 6.9, 1-CH3); 1.61 (1H, d,
J = 15.0, H-4); 2.14 (1H, d, J = 15.0, H-4); 2.70 (2H, q, J = 7.2, CH3CH2); 4.48 (1H, q, J = 6.9, H-1); 7.12-7.38
(4H, m, H Ar). Found, %: C 83.00; H 10.83; N 5.87. M+ 245. C17H27N. Calculated, %: C 83.37; H 11.02;
N 5.71. M 245.
Methyl (E)-3-{1,1,3-Trimethyl-3-[2-(ethoxymethyl)phenyl]butyl}(ethyl)aminoacrylate (5).
A
mixture of benzazepine 3 (1 g, 4.3 mmol) and ethyl propiolate (0.52 g, 5.3 mmol) was boiled for 48 h (check by
TLC). The solvent was distilled in vacuum. The residue was chromatographed (eluent ethyl acetate–hexane,
1:40 to 1:10). Compound 5 (0.32 g: 20%) was isolated as a yellow oil. IR spectrum, ν, cm-1: 1730 (CO), 1645
1
(C=C). H NMR spectrum, δ, ppm (J, Hz): 1.10 (3H, s, CH3); 1.17 (3H, t, J = 6.8, NCH2CH3); 1.25 (3H, t,
J = 7.1, CH3CH2O); 1.28 (3H, t, J = 7.1, CH3CH2O); 1.42 (3H, s, CH3); 1.44 (3H, s, CH3); 1.51 (3H, s, CH3);
1.69 (2H, s, CH2); 3.20 (2H, m, NCH2CH3); 4.12 (2H, q, J = 7.1, CH3CH2O); 4.40 (2H, s, CH2O); 4.42 (2H, m,
CH3CH2CO2); 5.62 (1H, d, J = 13.1, CH=); 7.55 (1H, d, J = 13.1, CH=). Found, %: C 73.21; H 10.01; N 3.91.
M+ 375. C23H37NO3. Calculated, %: C 73.60; H 9.87; N 3.73. M 375.
Methyl (E)-3-{1,1,3-Trimethyl-3-[2-(1-ethoxyethyl)phenyl]butyl}(ethyl)aminoacrylate (6) was
obtained by the procedure described above from benzazepine 4 (1 g, 4 mmol) in a yield of 0.35 g (22%) as a
light-yellow oil. IR spectrum, ν, cm-1: 1740 (CO), 1638 (C=C). 1H NMR spectrum, δ, ppm (J, Hz): 1.12 (3H, s,
CH3); 1.19 (3H, t, J = 6.9, NCH2CH3); 1.26 (3H, t, J = 7.1, CH3CH2CO2); 1.29 (3H, t, J = 7.1, CH3CH2CO2);
1.43 (3H, s, CH3); 1.45 (3H, s, CH3); 1.53 (3H, s, CH3); 1.62 (3H, d, J = 6.9, CH3CH); 1.70 (2H, s, CH2); 3.32
(2H, m, N-CH2CH3); 4.12 (2H, q, J = 6.9, CH3CH2O); 4.32 (1H, q, J = 6.9, CH3CH); 4.43 (2H, q, J = 7.1,
CH3CH2CO2); 5.70 (1H, d, J = 13.5, CH=); 7.60 (1H, d, J = 13.5, CH=). Found, %: C 74.25; H 10.41; N 3.91.
M+ 375. C24H39NO3. Calculated, %: C 73.60; H 10.02; N 3.60. M 375.
The investigations were carried out within the framework of a joint project of the Russian Foundation
for Basic Research (Grant No. 08-03-90451) and the National Academy of Sciences of Ukraine.
1250